Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment

Affiliations

¹ Department of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.
² Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.

Editorial

Beatrice Foglia et al. Int J Mol Sci. 2023.

. 2023 Jul 31;24(15):12224.

doi: 10.3390/ijms241512224.

¹ Department of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.
² Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.

Abstract

The most common form of primary liver malignancy is hepatocellular carcinoma (HCC) [...].

The authors declare no conflict of interest.

1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
1. Siegel R.L., Miller K.D., Wagle N.S., Jemal A. Cancer statistics, 2023. CA Cancer J. Clin. 2023;73:17–48. doi: 10.3322/caac.21763. - DOI - PubMed
1. Montgomery E.J., Xing E., Campbell M.J., Li P.-K., Blachly J.S., Tsung A., Coss C.C. Constitutively Active Androgen Receptor in Hepatocellular Carcinoma. Int. J. Mol. Sci. 2022;23:13768. doi: 10.3390/ijms232213768. - DOI - PMC - PubMed
1. Ma W.L., Hsu C.L., Wu M.H., Wu C.T., Wu C.C., Lai J.J., Jou Y.S., Chen C.W., Yeh S., Chang C. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology. 2008;135:947–955.e5. doi: 10.1053/j.gastro.2008.05.046. - DOI - PMC - PubMed
1. Akkız H. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma. Int. J. Mol. Sci. 2023;24:3941. doi: 10.3390/ijms24043941. - DOI - PMC - PubMed